HealthEquity, Inc. (NASDAQ:HQY) Shares Bought by Thrivent Financial for Lutherans

Thrivent Financial for Lutherans lifted its stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 33.3% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 293,624 shares of the company's stock after buying an additional 73,404 shares during the period. Thrivent Financial for Lutherans owned approximately 0.34% of HealthEquity worth $24,033,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of HQY. International Assets Investment Management LLC acquired a new position in HealthEquity during the second quarter worth about $35,000. Paladin Wealth LLC acquired a new stake in HealthEquity in the third quarter valued at approximately $39,000. GAMMA Investing LLC increased its holdings in shares of HealthEquity by 114.8% during the second quarter. GAMMA Investing LLC now owns 595 shares of the company's stock worth $51,000 after buying an additional 318 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of HealthEquity during the 2nd quarter valued at $73,000. Finally, 1620 Investment Advisors Inc. bought a new stake in HealthEquity during the 3rd quarter worth $112,000. Institutional investors and hedge funds own 99.55% of the company's stock.

HealthEquity Stock Performance

NASDAQ:HQY traded up $0.28 on Wednesday, hitting $102.95. The stock had a trading volume of 570,121 shares, compared to its average volume of 624,682. The business's 50-day simple moving average is $86.10 and its two-hundred day simple moving average is $81.42. The stock has a market cap of $8.99 billion, a price-to-earnings ratio of 85.22, a price-to-earnings-growth ratio of 1.55 and a beta of 0.52. HealthEquity, Inc. has a 52-week low of $62.10 and a 52-week high of $103.69. The company has a quick ratio of 4.10, a current ratio of 4.10 and a debt-to-equity ratio of 0.51.

HealthEquity (NASDAQ:HQY - Get Free Report) last released its earnings results on Tuesday, September 3rd. The company reported $0.66 EPS for the quarter, topping analysts' consensus estimates of $0.50 by $0.16. HealthEquity had a net margin of 9.61% and a return on equity of 9.01%. The company had revenue of $299.93 million for the quarter, compared to analysts' expectations of $284.48 million. As a group, research analysts predict that HealthEquity, Inc. will post 2.27 earnings per share for the current year.

Insider Buying and Selling

In other news, Director Robert W. Selander sold 8,250 shares of HealthEquity stock in a transaction that occurred on Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total transaction of $684,585.00. Following the completion of the sale, the director now owns 54,719 shares of the company's stock, valued at approximately $4,540,582.62. The trade was a 13.10 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Frank Corvino sold 1,039 shares of the firm's stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $96.10, for a total transaction of $99,847.90. Following the transaction, the director now directly owns 3,784 shares in the company, valued at $363,642.40. This trade represents a 21.54 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 10,536 shares of company stock worth $884,517. Corporate insiders own 2.20% of the company's stock.

Wall Street Analyst Weigh In

HQY has been the topic of a number of analyst reports. BTIG Research upped their price target on HealthEquity from $110.00 to $130.00 and gave the company a "buy" rating in a research report on Thursday, November 14th. The Goldman Sachs Group began coverage on shares of HealthEquity in a research note on Friday, November 15th. They issued a "neutral" rating and a $108.00 target price for the company. Royal Bank of Canada reissued an "outperform" rating and issued a $92.00 price target on shares of HealthEquity in a report on Wednesday, September 4th. Barrington Research reiterated an "outperform" rating and set a $105.00 price objective on shares of HealthEquity in a research note on Friday, September 20th. Finally, JMP Securities restated a "market outperform" rating and issued a $105.00 price objective on shares of HealthEquity in a research report on Wednesday, September 4th. One analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat, HealthEquity has an average rating of "Moderate Buy" and a consensus target price of $107.23.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.